Changes in myocardial oxidative metabolism after biventricular pacing as evaluated by [11C]acetate positron emission tomography

Annals of Nuclear Medicine

Volumn 17, Issue 7, 2003, Pages 605-608

  Araki, Tsutomu ^a   Yoshida, Naohiro ^a   Tsuchiya, Taketsugu ^a   Ikeda, Masatoshi ^a   Namura, Masanobu ^a   Higuchi, Takahiro ^a   Taki, Junichi ^b  

^a KANAZAWA CARDIOVASCULAR HOSPITAL   (Japan)

^b NONE

Author keywords

Biventricular pacing; Myocardial oxidative metabolism; Positron emission tomography; 11C acetate

Indexed keywords

ACETIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON 11; DIURETIC AGENT; FUROSEMIDE; SPIRONOLACTONE;

AEROBIC METABOLISM; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHY; CASE REPORT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QRS COMPLEX;

EID: 0242577252     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03006676     Document Type: Article

References (9)

1. Cazeau S, Leclerco C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and interventricular conduction delay. N Engl J Med 2001; 344: 873-880.
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
3. Saxon LA, Marco TD, Schafer J, Chatterjee K, Kumar UN, Foster E, et al. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002; 105: 1304-1310.
4. Beanlands RS, Bach DS, Raylman R, Armstrong WF, Wilson V, Montieth M, et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using C-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol 1993; 22: 1389-1398.
5. Katz AM. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 1986; 73 (3 Pt 2): III 184-190.
6. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Group. N Engl J Med 1991; 325: 1468-1475.
7. O'Connor CM, Gattis WA, Uretsky BF, Adams KF Jr, McNulty SE, Grossman SH, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999; 138 (1 Pt 1): 78-86.
8. Nelson GS, Berger RD, Fetics BJ, Talbot M, Hare JM, Kass DA, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102: 3053-3059.
9. Ukkonen H, Beanlands RS, Burwash IG, de Kemp RA, Nahmias C, Fallen E, et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003; 107: 28-31.